Ocumension Therapeutics
HKEX:1477

Watchlist Manager
Ocumension Therapeutics Logo
Ocumension Therapeutics
HKEX:1477
Watchlist
Price: 4.39 HKD -1.79%
Market Cap: 3.6B HKD
Have any thoughts about
Ocumension Therapeutics?
Write Note

Wall Street
Price Targets

Price Targets Summary
Ocumension Therapeutics

Wall Street analysts forecast Ocumension Therapeutics stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Ocumension Therapeutics is 10.12 HKD with a low forecast of 8.94 HKD and a high forecast of 12.52 HKD.

Lowest
Price Target
8.94 HKD
104% Upside
Average
Price Target
10.12 HKD
131% Upside
Highest
Price Target
12.52 HKD
185% Upside
Ocumension Therapeutics Competitors:
Price Targets
PLTH
Planet 13 Holdings Inc
184% Upside
JUBLPHARMA
Jubilant Pharmova Ltd
28% Upside
4540
Tsumura & Co
21% Upside
DHG
Dhg Pharmaceutical Joint-Stock Co
1% Upside
IPN
Ipsen SA
20% Upside
ALM
Almirall SA
47% Upside

Revenue
Forecast

Revenue Estimate
Ocumension Therapeutics

For the last 4 years the compound annual growth rate for Ocumension Therapeutics's revenue is 500%. The projected CAGR for the next 4 years is 73%.

500%
Past Growth
73%
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Ocumension Therapeutics

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
11%
Average Beat

Net Income
Forecast

Net Income Estimate
Ocumension Therapeutics

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-22%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Ocumension Therapeutics's stock price target?
Price Target
10.12 HKD

According to Wall Street analysts, the average 1-year price target for Ocumension Therapeutics is 10.12 HKD with a low forecast of 8.94 HKD and a high forecast of 12.52 HKD.

What is Ocumension Therapeutics's Revenue forecast?
Projected CAGR
73%

For the last 4 years the compound annual growth rate for Ocumension Therapeutics's revenue is 500%. The projected CAGR for the next 4 years is 73%.

Back to Top